Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 5$ C. next week

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Sep 08, 2021 10:51am

122 Views

Post# 33824600

RE:5$ C. next week

FTV, if I recall you did nail a previous SP predition, soooo your latest call caused me eyes to glaze over and sent me to my happy spot ;-> Chamange is back in the fridge for breaking through that $5 ceiling!

FredTheVoice wrote: Feeling the positive trend.

Some are pushing this thing north,

First step next week with some news on the NASH protocol.

5$ C break next week.

FTV.